A randomised, open label, controlled PK standard of care vs doravirine plus 2 nucleoside
reverse transcriptase inhibitors backbone in pregnant women initiating combination
antiretroviral therapy in the second trimester of pregnancy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Liverpool
Collaborators:
Desmond Tutu Health Foundation Liverpool School of Tropical Medicine